Clinical Trial

Exosomes for Hairloss Treatment

Terminated Early Phase 1
View on ClinicalTrials.gov →
Why the trial stopped
Per updated regulatory requirements, the site is ineligible to proceed. The clinical institution office has terminated the project.
Summary
Many people suffer from alopecia, which is caused by hereditary factors, emotional stress, and psychiatric disorders. There are devastating physical and psychological consequences as a result. Exosomes are isolated from donated human mesenchymal stem cells and purified using specific processing. This study is a randomized, double-blind, dose-escalation clinical trial designed to evaluate the efficacy and safety of exosomes therapy for alopecia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-10.
Status change: Not Yet Recruiting → Terminated 2026-05-26
Trial Details
NCT Number NCT06932393
Lead Sponsor Guangzhou Bio-gene Technology Co., Ltd
Conditions Hair Loss
Enrollment 16 participants
Start Date 2025-04-30
Primary Completion 2026-04-17 (estimated)
Study Completion 2026-04-17 (estimated)
Updated on ClinicalTrials.gov 2026-05-28